Ads
-
Related paper
- B Cell-Activating Factor (BAFF) and Ubiquitin Enzyme A20 as Functional Proteins in Targeted Therapy on Patients with Systemic Lupus Erythematosus
- A Case Report on Systemic Lupus Erythematosis, Lupus Nephritis, Acute Pancreatitis, Posterior Reversible Encephalopathy Syndrome (PRES), Macrophage Activating Syndrome (MAS)
- Serum DNase1, sTNFR1 and sTNFR2 as Risk Factors for Lupus Nephritis in Systemic Lupus Erythematosus Patients
- Human Umbilical Cord Mesenchymal Stem Cells Suppress Systemic Lupus Erythematosus Lesions by Rebalancing CD4+/CD8+ Cell Population
- The Relationship Between Thymosin β4 and Vitamin D3 in Systemic Lupus Erythmatosus Patients
- METHODS OF ASSESSMENT OF THE QUALITY OF LIFE OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
- Periodontitis Risk in Patients With and Without Systemic Lupus Erythematosus: A Retrospective Study
- Quality of life in patients with juvenile-onset systemic lupus erythematosus
- AMYLOSE RENALE COMPLIQUANT UN LUPUS ERYTHEMATEUX DISSEMINE RENAL AMYLOIDOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS
- LUPUS PNEUMONITIS AS THE INITIAL PRESENTATION OF SYSTEMIC LUPUS ERYTHEMATOSUS
